Severe Illness After Postvaccination COVID-19 Breakthrough Among Adults With and Without HIV

Risk of severe breakthrough COVID-19 infection is higher for people with HIV with moderately low CD4 cell counts johnshopkinssph jamanetworkopen

Keri N. Althoff, PhD, MPH, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, Rm E7142, Baltimore, MD 20295 .Ms Humes and Dr Althoff had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.Acquisition, analysis, or interpretation of data:

Lang, Humes, Coburn, Horberg, Watson, Jefferson, Park, Gordon, Akgün, Justice, Napravnik, Edwards, Browne, Agil, Silverberg, Skarbinski, Leyden, Stewart, Hogan, Gebo, Marconi, Althoff.Critical revision of the manuscript for important intellectual content: Lang, Humes, Coburn, Horberg, Watson, Jefferson, Park, Gordon, Akgün, Justice, Napravnik, Edwards, Browne, Agil, Silverberg, Skarbinski, Leyden, Stewart, Hogan, Gebo, Marconi, Williams, Althoff.Obtained funding:Fathi, Park, Gordon, Akgün, Justice, Napravnik, Edwards, Browne, Agil, Skarbinski, Leyden, Stewart, Hogan, Gebo.Dr Lang reported receiving grants from Canadian Institutes of Health Research , Alberta Innovates, and the University of Calgary paid to their institution.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

What is the association of masking behavior with SARS-CoV-2 infection?What is the association of masking behavior with SARS-CoV-2 infection? GWtweets SARSCoV2 COVID19 Masking Mask FaceMasks
Read more »

The prevalence of COVID-19 vaccine hesitancy among the sub-Saharan adolescent populationThe prevalence of COVID-19 vaccine hesitancy among the sub-Saharan adolescent population PLOSGPH GeorgeMasonU UniIbadan Harvard COVID19 coronavirus covid vaccine
Read more »

Molnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patientsMolnupiravir and nirmatrelvir-ritonavir treatments are effective in reducing mortality among high-risk COVID-19 patients HKUniversity COVID19 SARSCoV2 Mortality Molnupiravir NirmatrelvirRitonavir
Read more »

Estimating the all-cause excess mortalities due to COVID-19In a new study, researchers estimated all-cause excess death rates due to the coronavirus disease 2019 (COVID-19) pandemic.
Read more »